Delivery Order SPE2DB20D3505-SPE2DB24FU4C2
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lamotrigine ER 100 mg tablets. The contract has a firm fixed price of $9,108.60 and a completion date of June 4, 2025. The contract is not set-aside and represents an open competition. AmerisourceBergen Drug Corp is the prime contractor for this delivery order, which is part of a larger $999,999,999.00 Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $1,827.19 and covers the delivery of 4,568,198,149 tablets of Lamotrigine ER 200 mg, a medication used to treat epilepsy and bipolar disorder. The contract has an ultimate completion date of May 12, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamotrigine ER 25 mg tablets. The contract has a ceiling value of $1,990.68 and a completion date of October 25, 2024. It is priced as a firm fixed-price contract. Amerisourcebergen Drug Corp is a for-profit organization and a registered vendor in the System for Award Management (SAM). The company holds a substantial...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Lamotrigine ER 100 mg tablets. The contract has a firm fixed price and a ceiling value of $4,103.24. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Lamotrigine ER 50 mg tablets in quantities of 30 units, valued at $6,761.68. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract is scheduled for completion by October 24, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $3,943.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 250 mg tablets (30-count units), with an ultimate completion date of August 13, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Lamotrigine ER 25 mg tablets. The contract has a ceiling value of $4,212.78 and a period of performance through February 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,843.10, is for the delivery of Lamotrigine ER 300 mg tablets to support military healthcare programs. The contract has an ultimate completion date of July 29, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lamotrigine ER 300 mg tablets (30-count) under a firm fixed price contract valued at $1,471.86. The delivery order, issued on May 8, 2025, with an ultimate completion date of May 9, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of LAMOTRIGINE ER 250 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,610.84. The contract is a Firm Fixed Price arrangement and has an ultimate completion date of July 23, 2024. This order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB24FU4C2Delivery Order
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,248.34, is for the supply of Lamotrigine ER 50 mg tablets. It is a firm fixed-price contract with a completion date of June 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 6/7/24 |